These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 29632011)

  • 1. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole preexposure affects the Aspergillus fumigatus population in patients.
    Alanio A; Cabaret O; Sitterlé E; Costa JM; Brisse S; Cordonnier C; Bretagne S
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4948-50. PubMed ID: 22710122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.
    Snelders E; Karawajczyk A; Schaftenaar G; Verweij PE; Melchers WJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2425-30. PubMed ID: 20385860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Arendrup MC; Jensen RH; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
    Paul S; Diekema D; Moye-Rowley WS
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of Azole-Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?
    Bandegani A; Abastabar M; Sharifisooraki J; Abtahian Z; Vaseghi N; Khodavaisy S; Fakharian A; Khalilzadeh S; Modaresi MR; Haghani I; Ahmadi A; Ghazanfari M; Valadan R; Badali H
    Mycoses; 2024 Sep; 67(9):e13791. PubMed ID: 39239666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
    Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole-resistant Aspergillus fumigatus Containing a 34-bp Tandem Repeat in cyp51A Promoter is Isolated from the Environment in Japan.
    Onishi K; Muhammad Sarumoh B; Hagiwara D; Watanabe A; Kamei K; Toyotome T
    Med Mycol J; 2017; 58(2):E67-E70. PubMed ID: 28566661
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
    Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
    Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Genetic Stability on
    Dos Reis TF; Silva LP; de Castro PA; Almeida de Lima PB; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Malavazi I; Goldman GH
    G3 (Bethesda); 2018 Jan; 8(1):265-278. PubMed ID: 29150592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
    Mellado E; Garcia-Effron G; Alcázar-Fuoli L; Melchers WJ; Verweij PE; Cuenca-Estrella M; Rodríguez-Tudela JL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1897-904. PubMed ID: 17371828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.
    Toyotome T; Fujiwara T; Kida H; Matsumoto M; Wada T; Komatsu R
    J Infect Chemother; 2016 Sep; 22(9):648-50. PubMed ID: 27050399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
    Simon L; Déméautis T; Dupont D; Kramer R; Garnier H; Durieu I; Sénéchal A; Reix P; Couraud S; Devouassoux G; Lina B; Rabodonirina M; Wallon M; Dannaoui E; Persat F; Menotti J
    Int J Antimicrob Agents; 2021 Dec; 58(6):106447. PubMed ID: 34619334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
    Doğan Ö; Gülmez D; Arıkan Akdağlı S
    Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.